Brazilian workshop model to train investigators in chronic graft-versus-host disease clinical trials according to the 2005-2006 National Institutes of Health recommendations

Brazilian workshop model to train investigators in chronic graft-versus-host disease clinical trials according to the 2005-2006 National Institutes of Health recommendations

BACKGROUND: The lack of standardization of clinical diagnostic criteria, classification and severity scores of chronic graft-versus-host disease led the National Institutes of Health to propose consensus criteria for the purpose of clinical trials. METHODS: Here we describe a one-day workshop model...

Full description

Bibliographic Details
Main Authors:	Rita de Cássia Barbosa da Silva Tavares, Márcia de Matos Silva, Luis Fernando da Silva Bouzas, Maria Cláudia Rodrigues, Afonso Celso Vigorito, Vaneusa Funke, Marcos Mauad, Maria Elvira Pizzigatti Correa, Clarissa Vasconcellos de Souza, Elenaide Nunes, Alessandra Ferrari, Ariana Paixão, Talita Martins, Érika Pallottino, Mary Evelyn Dantas Flowers
Format:	Article
Language:	English
Published:	Elsevier 2011-10-01
Series:	Revista Brasileira de Hematologia e Hemoterapia
Subjects:	Graft vs. host disease Hematopoietic stem cell transplantation Training
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000500012

Similar Items

Immune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantation
by: Severin eZinöcker, et al.
Published: (2012-11-01)

CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation
by: Antonella Mancusi, et al.
Published: (2019-12-01)

Bone Marrow Transplantation 1957-2019
by: Elizabeth Simpson, et al.
Published: (2019-06-01)

Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review
by: Cesar Daniel Villarreal Villarreal, et al.
Published: (2016-06-01)

Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model
by: Aude Burlion, et al.
Published: (2017-06-01)

Editorial: Cellular Therapies: Past, Present and Future
by: Ralf Dressel, et al.
Published: (2018-08-01)

Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD
by: Deepika Raman, et al.
Published: (2023-04-01)

Rehabilitation in Children With Sclerodermoid Chronic Graft-Versus-Host Disease: Case Series
by: Minji Jung, et al.
Published: (2019-06-01)

<b>Treatments and supportive therapies for oral manifestations of chronic graft-versus-host disease
by: Rafaella Gabriel Maiolino, et al.
Published: (2016-06-01)

Umbilical cord blood transplantation: Still growing and improving
by: Xiaoyu Zhu, et al.
Published: (2021-11-01)

Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation
by: Riccardo Masetti, et al.
Published: (2021-01-01)

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
by: Abedin S, et al.
Published: (2020-11-01)

Treatment of oral chronic graft-versus-host disease: a retrospective cohort study
by: Gabriela de Assis Ramos, et al.
Published: (2021-10-01)

The Evolution of T Cell Depleted Haploidentical Transplantation
by: Franco Aversa, et al.
Published: (2019-11-01)

The incidence and risk factors of chronic rejection in acutely rejected pediatric liver transplantation
by: S. M. Dehghani, et al.
Published: (2022-01-01)

Advances in preclinical hematopoietic stem cell models and possible implications for improving therapeutic transplantation
by: Ellen Fraint, et al.
Published: (2021-03-01)

MiR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence
by: Sadaf eAtarod, et al.
Published: (2016-03-01)

Membranous nephropathy succeeding autologous hematopoietic stem cell transplant: a case report
by: Sanda Mrabet, et al.
Published: (2018-03-01)

A concise review on factors influencing the hematopoietic stem cell transplantation main outcomes
by: Mohammad Rafiee, et al.
Published: (2021-06-01)

Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation
by: Rafaela Holtappels, et al.
Published: (2020-04-01)

Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases
by: Irina Zaidman, et al.
Published: (2023-05-01)

One-way donor-to-recipient human leukocyte antigen mismatch and graft-versus-host disease in liver transplantation: an observational study of a single-center experience in Korea
by: Seung Hyuk Yim, et al.
Published: (2023-12-01)

Editorial: Langerhans Cells and How Skin Pathology Reshapes the Local Immune Environment
by: Clare L. Bennett, et al.
Published: (2019-02-01)

Bendamustine Conditioning Skews Murine Host DCs Toward Pre-cDC1s and Reduces GvHD Independently of Batf3
by: Megan S. Molina, et al.
Published: (2020-07-01)

Importancia del estudio del quimerismo en el trasplante alogénico de médula ósea IMPORTANCE OF THE STUDY OF CHIMERISM IN THE ALLOGENEIC BONE MARROW TRANSPLANTATION
by: Ana M Amor Vigil, et al.
Published: (2003-12-01)

The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease
by: Sandeep Kumar, et al.
Published: (2018-12-01)

Case report: Sudden onset optic neuritis shortly after SARS-CoV-2 vaccination in an allogeneic hematopoietic stem cell transplant recipient with chronic graft-vs.-host disease
by: Chiang Chu, et al.
Published: (2023-06-01)

Cyclophosphamide-Induced Tolerance in Allogeneic Transplantation: From Basic Studies to Clinical Application
by: Koji Kato, et al.
Published: (2020-01-01)

Pityriasis rubra pilaris‐like graft‐vs‐host disease following allogeneic stem cell transplant in two patients
by: Jennifer Y. Wang, et al.
Published: (2019-12-01)

Positive Effects of Oral Antibiotic Administration in Murine Chronic Graft-Versus-Host Disease
by: Shinri Sato, et al.
Published: (2021-04-01)

Immunoregulatory CD4-CD8- T cells as a potential therapeutic tool for transplantation, autoimmunity and cancer
by: Erin E Hillhouse, et al.
Published: (2013-01-01)

Predicting the clinical outcome of allogeneic hematopoietic stem cell transplantation: the long and winding road towards validated immune biomarkers
by: Alessandra eForcina, et al.
Published: (2013-03-01)

Using Gene Editing Approaches to Fine-Tune the Immune System
by: Kristina Pavlovic, et al.
Published: (2020-09-01)

Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects
by: Grégory Ehx, et al.
Published: (2017-05-01)

ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide
by: Laura Solán, et al.
Published: (2019-10-01)

Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia
by: Justin Loke, et al.
Published: (2021-04-01)

Editorial: Advances in ocular surface disease
by: Hong Qi, et al.
Published: (2024-01-01)

AAV-mediated expression of HLA-G for the prevention of experimental ocular graft vs. host disease
by: Jacob P. Nilles, et al.
Published: (2023-06-01)

Activated CD4 + T lymphocyte is a potential biomarker for acute graft-vs.-host disease after hematopoietic stem cell transplantation in children with transfusion-dependent β-thalassemia
by: Ken Huang, et al.
Published: (2022-09-01)

Complement and CD4+ T cells drive context-specific corneal sensory neuropathy
by: Derek J Royer, et al.
Published: (2019-08-01)